Taxotere and Adriamycin/Cytoxan (AC) Validation in Breast Cancer Patients
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Taxotere/Docetaxel|DRUG: Adriamycin/Cytoxan|DRUG: doxorubicin
Sponsor: Mothaffar Rimawi
Collaborators: Baylor College of Medicine